[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention Group:96 patients will receive naproxen 250mg / 2x day for 5 consecutive days and standard treatmentPlacebo Group: 96 patients will receive placebo 250mg / 2x day for 5 consecutive days (microcrystalline cellulose) and standard treatmentStandard treatment: amoxacillin / clavulanate (100mg / kg / day) divided into 3 taken via the EV route; azithromycin 500mg once daily via the EV or VO (if spontaneous) or levofloxacin 750mg / day; oseltamivir; 75 mg every 12hrs by SNE or via oral. Oseltamivir should be used for a maximum of 5 days and withdrawn if the SARS-Covid2 PCR test is positive.;Drug", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 860, "treatment_name": "Naproxen", "treatment_type": "Non-steroidal anti-inflammatory", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]